PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases, University of Colorado Denver Anschutz Medical Campus, 12700 E. 19th Avenue, Aurora CO 80045, United States. Electronic address: sias.scherger@cuanschutz.edu.\', \'Division of Infectious Diseases, University of Colorado Denver Anschutz Medical Campus, 12700 E. 19th Avenue, Aurora CO 80045, United States.\', \'Division of Infectious Diseases, University of Colorado Denver Anschutz Medical Campus, 12700 E. 19th Avenue, Aurora CO 80045, United States; Hospital Infantil de México, Federico Gómez, México City, México.\', \'Division of Infectious Diseases, University of Colorado Denver Anschutz Medical Campus, 12700 E. 19th Avenue, Aurora CO 80045, United States; Division of Infectious Diseases, Rocky Mountain Regional Veterans Affairs Medical Center, 1700 N Wheeling St, Aurora, CO 80045, United States; Supported by The Emily Foundation for Medical Research, One Beacon Street, 15th Floor, Boston MA 02108, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0306-9877(20)31065-310.1016/j.mehy.2020.110053
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 32758889
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • Rethinking interleukin-6 blockade for treatment of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all